137 related articles for article (PubMed ID: 35392730)
1. Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Ekhtiari Kolour SR; Shahrami B; Kargar M; Taghvaye Masoumi H; Amini S; Vaezi M; Hadjibabaie M; Mohammadi M; Sadeghi K
J Oncol Pharm Pract; 2023 Jul; 29(5):1112-1118. PubMed ID: 35392730
[TBL] [Abstract][Full Text] [Related]
2. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
[TBL] [Abstract][Full Text] [Related]
3. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
4. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
[TBL] [Abstract][Full Text] [Related]
5. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
[No Abstract] [Full Text] [Related]
6. Assessment of Antimicrobial Utilization among Cancer Patients with Febrile Neutropenia at the Lebanese Hospitals.
Cherri S; Malaeb D; Shouman L; Fahs I; Hallit R; Hallit S; Malaeb B; Salameh P
Curr Drug Saf; 2023; 18(4):496-503. PubMed ID: 35726429
[TBL] [Abstract][Full Text] [Related]
7. The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Perreault S; McManus D; Bar N; Foss F; Gowda L; Isufi I; Seropian S; Malinis M; Topal JE
Transpl Infect Dis; 2019 Apr; 21(2):e13059. PubMed ID: 30737868
[TBL] [Abstract][Full Text] [Related]
8. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study.
Rosa RG; Goldani LZ; dos Santos RP
BMC Infect Dis; 2014 May; 14():286. PubMed ID: 24884397
[TBL] [Abstract][Full Text] [Related]
9. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes.
Wright JD; Neugut AI; Ananth CV; Lewin SN; Wilde ET; Lu YS; Herzog TJ; Hershman DL
JAMA Intern Med; 2013 Apr; 173(7):559-68. PubMed ID: 23460379
[TBL] [Abstract][Full Text] [Related]
10. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
[TBL] [Abstract][Full Text] [Related]
11. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
Pettit N; Boadu D; Bischof JJ
Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
[TBL] [Abstract][Full Text] [Related]
12. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
[TBL] [Abstract][Full Text] [Related]
13. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
[TBL] [Abstract][Full Text] [Related]
14. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T; Robinson PD; Ammann RA; Fisher B; Patel P; Phillips R; Beauchemin MP; Carlesse F; Castagnola E; Davis BL; Elgarten CW; Groll AH; Haeusler GM; Koenig C; Santolaya ME; Tissing WJE; Wolf J; Alexander S; Hu H; Dupuis LL; Sung L
J Clin Oncol; 2023 Mar; 41(9):1774-1785. PubMed ID: 36689694
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside use in paediatric febrile neutropenia - Outcomes from a nationwide prospective cohort study.
McMullan BJ; Haeusler GM; Hall L; Cooley L; Stewardson AJ; Blyth CC; Jones CA; Konecny P; Babl FE; Mechinaud F; Thursky K;
PLoS One; 2020; 15(9):e0238787. PubMed ID: 32936822
[TBL] [Abstract][Full Text] [Related]
16. Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation.
Sardzikova S; Andrijkova K; Svec P; Beke G; Klucar L; Minarik G; Bielik V; Kolenova A; Soltys K
Sci Rep; 2024 Mar; 14(1):5504. PubMed ID: 38448687
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
18. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
20. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
